Zennea is conducting clinical trials to make the first clinically-proven therapeutic wearable for chronic snoring and mild OSA.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 15, 2022 | Convertable Note | — | 1 | — | — | Detail |
Jan 10, 2020 | Seed | — | 1 | — | — | Detail |
Jul 4, 2019 | Convertable Note | — | 1 | — | — | Detail |
Feb 2, 2019 | Convertable Note | — | 1 | — | — | Detail |
Mar 8, 2018 | Pre-seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
HAX | — | Convertable Note |